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Summary 
In rabbits nearly all B lymphocytes express the glycoprotein CD5, in contrast to mice and hu- 
mans, where  only a small proportion of B  cells  express this molecule (Raman,  C.,  and K.L. 
Knight.  1992.J.  Immunol.  149:3858-3864).  CD5 + B cells appear to develop early in ontogeny 
and be maintained throughout life by self-renewal. The function of CD5 on B cells is still un- 
known. We showed earlier that "positive" selection occurs during B lymphocyte development 
in the rabbit appendix. This selection favors B  cells  expressing surface immunoglobulins with 
VHa2  structures in the first and third framework regions  (Pospisil,  P,.., G.O. Young-Cooper, 
and tL.G. Mage.  1995.  Proc. Natl. Acad.  Sci. USA. 92:6961-6965).  Here we report that F(ab')2 
fragments, especially those bearing VHa2 framework region determinants,  specifically interact 
with the B cell-surface glycoprotein CD5. This interaction can be inhibited by anti-CD5 anti- 
bodies. Furthermore, immobilized F(ab')2 fragments selectively bind CD5 molecules in appen- 
dix cell lysates.  Interactions of V H framework region structures with CD5 may affect mainte- 
nance  and  selective  expansion  of particular  B  cells  and  thus  contribute  to  autostimulatory 
growth of autoimmune or transformed cells. 
D 
uring B cell development a rigorous selection process 
acts on newly formed B cells. Those beating self-reac- 
tive Ig molecules can be eliminated (1,  2), undergo recep- 
tor editing  (3,  4)  or develop clonal anergy (5-7).  In addi- 
tion,  B  cells  appear to receive positive signals  for survival 
(8-10). Superantigens or self-antigens interacting with evo- 
lutionarily  conserved  "family-specific"  sequences  in  the 
first and third  framework regions  (FR) I  and  FR3)  of the 
VH may have the potential to significantly skew the com- 
position of the B cell repertoire (10-12). 
In normal rabbits of the VHa2 haplotype, the majority of 
peripheral  B  cells  that  have  undergone  a  productive VH- 
DH-JH gene rearrangement use the VHa2 allotype-encoding 
VH1  gene  (13--15).  The VHa2  specificities were  found  to 
correlate with  consistent  differences in  the amino acids at 
certain positions in FI<I and FR3 (13,  16).  Alicia (all) VH- 
mutants  (17)  have a small deletion encompassing the  VH1 
gene at the 3'  end of the VH cluster (13,  15)  thus most of 
the B  cells  in young all/all rabbits are VHa2  negative. We 
showed earlier that B cells producing surface immunoglob- 
ulin with Ft<I and FR3 VHa2 allotypic structures are pref- 
1Abbreviations used in this paper: all, Alicia; BCP,., B cell receptor; FP,., 
framework region. 
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erentially expanded and positively selected during their de- 
velopment in the  appendix  (18).  The antigen  or Iigand(s) 
responsible for this selection, however, were not determined. 
In this study we provide evidence for CD5-VH framework 
region  interaction.  The  interaction  between  CD5  and  B 
cell  surface immunoglobulin  may affect maintenance  and 
selective expansion of particular B  cells and may be a pro- 
moting factor in  the  evolution  of autoimmune  or  trans- 
formed cells. 
Materials  and Methods 
Animals, Reagents, and Antibodies.  Rabbits of the VHa2 (F-I) 
or VH mutant all (F-I) haplotype were bred and raised in our own 
National  Institute  of Allergy  and  Infections  Diseases allotype- 
defined  pedigreed  colonies.  The  antibodies  used  in  this  study 
were mouse mAbs to rabbit CD5, RCD5 (19) and human CD5, 
T1 or T1-RD1  (Coulter  Corp., Hialeah,  FL), biotin-conjugated 
mouse anti-rabbit  CD4 and mouse anti-rabbit CD8 (Spring Val- 
ley Laboratories Inc., Woodbine, MD), biotin conjugated  poly- 
donal anti-rabbit IgM (Southern  Biotechnology Associates, Bir- 
nfingham, AL), biotin-conjugated goat anti-mouse  IgG and FITC- 
labeled normal goat IgG (Jackson ImmunoResearch Laboratories, 
Inc.,  West Chester,  PA), avidin  conjugated  to biotinylated  glu- 
cose oxidase  (ABC-GO; Vector Laboratories,  Inc.,  Burlingame, 
CA),  nitro  blue  tetrazolium  in  conjugation  with  5-bromo- 
4-chloro-3-indotyl phosphate  (Sigma Chemical  Co.,  St.  Louis, 
MO),  Dynabeads  M-450  and  M-280  streptavidin  (Dynal  Inc., 
Great Neck, NY). 
1279  The Journal of Experimental Medicine ￿9 Volume 184  October 1996 1279-1284 Figure 1.  Biotinylated F(ab')2 fragments stain dark zone cells of appendix germinal center and the staining is inhibited  by anti-Cl)5 antibody.  Appen- 
dix tissue sections were stained with (a) VHa2  + F(ab')2-biotin;  (b) anti-CD5 antibody RCD5; (c) anti-CD5 antibody RCI)5 followed by VHa2  ~ F(ab')~- 
biotin; (a  t) VH-biotin; (e) purified V. followed by anti-CD5 (T1) antibody. 
Tissue Staining and lmmutwhistochemistry.  The  preparation  and 
purification  of F(ab')2  fragments  was  described  previously  (20). 
Briefly, a globulin fraction  of rabbit  serum was  first prepared  by 
precipitation with ammonium sulfate  (50% saturation).  The pre- 
cipitated  proteins  were  dialyzed  against  acetate  buffer,  pH  4.5, 
and  digested  with  pepsin  (2  mg/100  mg  protein)  for  18  h  at 
37~  Digests were dialyzed against PBS. The residual undigested 
IgG was removed with protein A-Sepharose. The isolation of VH 
fragments was described previously (21).  The purified F(ab')2 and 
V H were biotinylated with a biotinylation kit using NHS-LC-biotin 
(Pierce Chemical Co., Rockford,  IL).  Semithin 7-1.am serial sec- 
tions of mutant  VHa2-  rabbit  appendix  collected at 6  wk of age 
were cut and incubated as described (18).  In Fig. 1, tissue sections 
were  stained  with  the  primary  reagent,  mouse  anti-rabbit  CD5 
mAb, RCI)5 (b and c) or isotype-matched control, normal mouse 
IgG2a (a) tbllowed by VHa2 F(ab')2-biotin (a and c) or biotin-con- 
jugated goat anti-mouse  IgG  (Jackson  hnmunoResearch Labora- 
tories)  (b). In (d) the tissue section was stained with VH-biotin and in 
(e) with VH followed by anti-CD5  (T1)  antibody and then with 
biotin-conjugated  goat anti-mouse  IgG. The sections were then 
incubated  with  ABC-GO  and  labeled  cells  visualized  by  nitro 
blue tetrazolium in conjunction with BCIP. 
CellAttachment  Assay,  Iinnaulon  4  flat-bottom plates  (Dyna- 
tech Laboratories,  Inc., Alexandria, VA) were coated with VHa2 + 
or mutant  VHa2-  F(ab')2  fragments  diluted  in  (IA  M  NaHCO 3 
and incubated at 4~  overnight (according to the directions from 
GIBCO BFZL, Gaithersburg,  MD).  NaHCO  3 alone was  added  to 
the control wells. The plates were washed three times with Dul- 
becco's PBS and  100  btl of 2% BSA was added to each well for 2 h 
at  room  temperature  to  block  plates.  After another  wash  with 
PBS  100  t*I  of CD4/CD8-depleted  or  IgM-depleted  appendix 
cell suspensions in PBS (107/ml) were added and incubated for 1 h 
at 37~  To isolate  CD4/CD8  or IgM-depleted appendix  cells, 
cells were first incubated with biotin-conjugated mouse anti-rab- 
bit CD4 and mouse anti-rabbit  CD8 mAbs or biotin-conjugated 
polyctonal  anti-rabbit  IgM.  After  washing  with  PBS-I%  BSA, 
the cells were incubated with Dynabeads M-280 streptavidin and 
bound  cells were  removed  using a  magnet  (MPC;  Dynal  Inc.). 
The plates were rinsed very gently three times with PBS and cells 
fixed with 100 ~1 of formalin solution (10% in PBS) for 3(1 rain at 
room temperature followed by addition of 50 I~l of toluidine blue 
(1%  [wt:vol]  in  10%  formalin  solution)  and  incubation  for  an- 
other  30  min.  After  extensive  washing  with  deionized  water, 
plates  were air dried,  cells solubilized by addition  of 1()0 ~.1 2% 
SI)S  and  incubation  for  15  rain  at  37~  and  absorbance  was 
measured  at  650  nm  using  a  microtiter plate  reader  (Molecular 
Devices Corporation,  Menlo Park,  CA). The relative absorbance 
was calculated as a ratio of each sample to the control. 
Flow Cytonletry.  Total ,appendix  cells were first incubated with 
VHa2 + F(ab')2-biotin then washed with PBS and stained with flun- 
rescein-conjugated  goat  anti-rabbit  IgM  and  streptavidin-PE 
conjugate.  Cells stained with BSA-biotin and  FITC-labeled nor- 
real goat  IgG  served as  a  negative  control.  CD4/CD8  depleted 
appendix  cells (isolated as described above)  were incubated  with 
BSA-biotin, mutant  Vna2-  F(ab')2-biotin, VHa2 + F(ab')2-biotin, 
or unlabeled  anti-CD5  antibody  (clone T1)  followed by  VHa2 + 
F(ab')2-biotin  for 30 rain at 4~  The cells were washed and  in- 
cubated  for 30  mm  at  4~  with  streptavidin-fluorescem  conju- 
gate.  For competitive inhibition studies, total appendix cells were 
incubated  with  a  nonsaturating  amount  of PE-conjugated  anti- 
CD5  (CD5-PE;  clone  TI-IKI)I).  PE-conjugated  mouse  lgG2a 
served as a negative control. I)ifferent concentrations of F(ab')2 or 
nonconjugated  anti-CD5  were  incubated  with  the  1{)  p,g anti- 
CD5-PE for 40 rain at 4~ 
CD5 Isolations  from Appendix  Cell Lysates.  5  X  10  a  appendix 
cells were isolated from 2-wk-old Vu-mutant  (ali/ali) rabbits with 
no endogenous VHa2  nmlecules.  Isolated  cells were biotinylated 
and cell lysates  prepared with a cellular labeling and inmmnopre- 
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Figure  2.  Attachment of appendix 
B cells to  F(ab')e-coated plates. The 
plates were coated with VHa2  + (ll and 
D)  or  mutant  VHa2- ([]  and  I) 
F(ab')e fragments. CD4/CD8-depleted 
("  and  [~) or IgM-depleted ([2] and 
m)  appendix cell suspensions in PBS 
(107/inl)  were added. After incuba- 
tion,  washing, and  staining  as  de- 
scribed in Materials and Methods, the 
relative absorbance was calculated as a 
ratio  of each sample to  the  control 
wells (buffer + BSA block). 
cipitation kit using biotin-7-NHS (Boehringer Mannheim, India- 
napolis, IN). To remove proteins that may bind nonspecifically  to 
the beads,  the lysate was first gently rocked with  100 ILl of un- 
coupled beads  (4  ￿  10  ~ beads/M)  for 30 min at 4~  and com- 
plexes  removed with  a  magnet.  This  step  was  repeated  three 
times.  The lysate was then divided into two equal  aliquots.  One 
aliquot was first incubated on a rocking platform at 4~  overnight 
with  300  btl  of Dynabeads  M-450  coupled  with  anti-human 
CD5 antibody (T1).  The complexes were collected with a mag- 
net and supernatants  removed carefully.  Both aliquots  were first 
precleared with VHa2- F(ab')2-coated Dynabeads M-280 for 5 h 
at  4~  on a  rocking platform and  then  incubated  with  VHa2  + 
F(ab')2-coated beads overnight at 4~  The complexes were col- 
lected again with a magnet and supernatants  removed. Dynabead 
complexes were washed twice in buffer 1 (50 mM Tris,  150 mM 
NaC1, and 0.1% NP-40) then twice in buffer 2 (50 mM Tris,  50 
mM  NaC1,  and 0.1%  NP-40)  and finally  once in  10  mM  Tris 
buffer, pH 7.5. The beads were boiled in SDS gel-loading reduc- 
ing buffer for 3 min and protein content analyzed by 15% SDS- 
PAGE Ready Gels (Bio-R.ad  Laboratories,  Hercules, CA) and a 
streptavidin-peroxidase  chemiluminescence technique  according 
to the manufacturer's instructions. 
Results 
Biotinylated F(ab ')2 Fragments Stain Dark Zone Cells of Ap- 
pendix  Germinal  Center and  the Staining  Is Inhibited  by anti- 
CD5 Antibody.  To identify a ligand for VH FR1 and FR3 
of B  cell surface immunoglobulin, we purified and biotiny- 
lated F(ab')2 fragments from rabbit IgG and used them as well 
as VH fragments (lacking an associated VL) to assess binding to 
appendix  germinal  center  cells  by immunohistochemistry. 
Biotin-labeled  F(ab')2 or VH fragments mainly stained ger- 
minal centers with high intensity in the dark zones and low 
intensity in the light zones  (Fig.  1, a and d).  A  similar pat- 
tern  of staining was  observed in  appendix  follicles  stained 
by  either  mouse  anti-rabbit  CD5  mAb  tLCD5  (1),  or  a 
mouse anti-human  CD5  mAb,  T1  (22)  (Fig.  1 b and data 
not  shown).  Staining  of the  germinal  centers  by  biotin- 
labeled F(ab')2 can be inhibited by prior incubation of tissue 
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sections with anti-CD5 antibodies (Fig.  1 c), suggesting that 
F(ab')2 fragments bind to the CD5 molecules on dark zone 
B  cells.  Similarly,  staining of the germinal centers by anti- 
CD5  antibody can be inhibited  by preincubation  of tissue 
sections  with purified V H (Fig.  1 e).  Thus,  the  interaction 
of CD5 and VH does not require VL. In addition, some but 
not all affinity-purified rabbit antibodies stain dark zones of 
the appendix and the staining can be inhibited by anti-CD5 
antibodies  (data not shown). Together these data argue that 
CD5-VH  interaction  is  framework  region  specific  and  is 
not dependent on antibody specificity, although changes in 
VH sequences can alter or eliminate binding. 
VHa2  + F(ab')2  Binds  to  IgM  + Appendix  B  Cells  and  the 
Binding Is Specifically Inhibited by anti-CD5 Antibody.  To de- 
termine which cell subpopulation binds to F(ab')2, we used 
a cell attachment assay. IgM-depleted cells, enriched for non- 
lymphoid cells,  did  not  bind  to  VHa2 +  or VHa2-  F(ab')2 
coated  plates  (Fig.  2).  In  contrast,  CD4/CDS-depleted 
appendix  cells,  mainly  IgM  +  B  cells,  showed  binding  to 
F(ab')2 fragments,  especially to  those  bearing  VHa2  deter- 
minants.  By flow cytometry, we  confirmed that  F(ab')2- 
biotin  stained  IgM-positive  appendix  B  cells  (Fig.  3  a). 
CD4/CDS-depleted  appendix  B  cells  stained  positively 
with  biotinylated  V.a2 +  F(ab')2  (solid thick line) but  not 
with mutant VHa2- F(ab')2 (Fig. 3 b, solid thin line). In ad- 
dition,  anti-CD5  mAb was able  to inhibit  the  interaction 
between  biotinylated  F(ab')2  and  appendix  B  cells  (dotted 
line,  Fig.  3  b).  This  is  consistent  with  the  immunohis- 
tochemistry  data  and  again  indicates  that  F(ab')2  binds  to 
CD5  on B  cells.  Under  conditions  of competitive  inhibi- 
tion,  F(ab')2 fragments were unable to inhibit binding of 
10  b~g of anti-CD5-PE  to  CD5  although  unlabeled  anti- 
CD5 antibody inhibited the binding (Fig. 3 c). Thus F(ab')2 
has a lower relative  avidity compared to the  anti-CD5  for 
the site on CD5 recognized by this mAb. 
Immobilized  F(ab')2 Fragments Isolate CD5 Molecules from 
Appendix Cell Lysates.  To isolate  the molecule on B  cells 
that interacts with F(ab')2 fragments, we covalently coupled a 
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Figure 3.  VHa2  + F(ab')2 binds to lgM  + appendix B cells and the bind- 
ing is specifically  inhibited by anti-CD5 antibody. (a) Total appendix cells 
were first incubated with  VHa2  + F(ab')2-biotin then  washed with  PBS 
and stained with fluorescein-conjugated goat anti-rabbit IgM and strepta- 
vidin-PE conjugate. Cells stained with BSA-biotin and FITC-labeled nor- 
mal goat lgG served as a negative control (not shown). (b) CD4/CD8 de- 
pleted  appendix  cells were  incubated  with  BSA-biotin  (broken  line), 
nmtant VHa2- F(ab')i-biotin  (solid  thin  line),  Vua2  + F(ab')2-biotin (solid 
thick  lira'),  or unlabeled anti-CD5 antibody (clone T1) followed by VHa2  + 
F(ab')2-biotin  (dotted line).  (c) Total appendix  cells  were incubated  with 10 btg 
PE-conjugated anti-CD5  antibody and different concentrations of either 
F(ab')2 (open  squares)  or unconjugated anti-CD5  antibody  (closed  circles). 
The data were expressed  as mean fluorescence minus control and percent 
inhibition calculated relative to CD5-PE in the absence of any inhibitor. 
purified  F(ab')2  fragments  to  Dynabeads.  Coated  beads 
were then used to isolate F(ab')2 ligand from lysates of sur- 
face biotinylated appendix cells. Similarly, anti-CD5  anti- 
bodies  (T1  and  RCDS)  were  coupled  to  the  Dynabeads. 
Anti-CD5 coated beads isolated two molecules (Fig. 4  and 
data not shown), one migrating at the position correspond- 
ing  to  its  expected  relative  molecular  mass  of  67,000 
(67,000 Mr)  on SDS-PAGE and one of 56,000  (56,000 Mr) 
most likely representing a  differently glycosylated form  of 
CD5  (23).  VHa2 +  F(ab')2-coupled beads  also isolated two 
molecules  from  the  cell  lysate  precleared  with  VHa2- 
F(ab')2-coupled beads. These had the same molecular mass 
as  those  from  anti-CD5  coated  beads,  the  major  one  of 
67,000  (67,000 Mr) and another one of 56,000  (56,000 Mr). 
The  56,000  molecule was  isolated by both  anti-CD5  and 
F(ab')2 coupled beads but not by control uncoupled beads; 
thus it is unlikely to represent a nonspecifically bound mol- 
ecule. Furthermore, when cell lysates from biotinylated ap- 
pendix cells were first preincubated with anti-CD5-coated 
beads,  these  two  molecules  were  no  longer  isolated  by 
VHa2 +  F(ab')2  beads.  In  addition,  some  affinity-purified 
rabbit antibodies also isolated CD5  molecules from cell ly- 
sates (data not shown)  arguing again that CD5-V H interac- 
tion is framework region specific and is not dependent on 
antibody specificity. 
Figure 4.  hnmobilized F(ab')2 fragments isolate CI)5 molecules from 
appendix cell  lysates.  SDS-PAGE shows that 67-kD and 56-kD CI)5 pro- 
teins were isolated by (a) anti-CD5  antibody TI  and (b) VHa2  + F(ab')_~- 
coated Dynabeads. CD5 molecules were not isolated by VHa2  + F(ab')e if 
the cell  lysate  was first preincubated with anti-CD5 coated beads (c). 
Discussion 
Interaction  of FR  structures  on  B  cells with  previously 
unidentified ligand(s) was postulated to contribute to antigen- 
independent signals to survive rather than undergo apopto- 
sis (18, 24). The data reported here demonstrate an interac- 
tion  between  CD5  and  B  cell  surface  immunoglobulin, 
most  likely  involving  framework  region  sequences.  We 
showed  earlier  that  "positive"  selection  occurs  during  B 
lymphocyte development in the rabbit appendix (18).  This 
selection favors B  cells with receptors bearingVHa2 + struc- 
tures in the first and third framework regions. VHa2 + struc- 
tures as F(ab')2 fragments bind IgM + B  cells irrespective of 
antibody  specificity and  the  binding  can  be  inhibited  by 
anti-CD5  antibodies.  Thus  CD5  is  a  potential  selecting 
ligand that contributes to survival and expansion of B  cells 
with VHa2 + surface IgM. 
Most dark zone B  cells in appendix germinal centers ex- 
press high  levels of CD5  (Fig.  1  b)  and  the  majority of B 
cells in  normal animals bear VHa2  framework  regions en- 
coded  by  the  VH1  gene  (13,  15).  The  presence  of both 
CD5  and VHa2  on  the  same  cell raises the  possibility of a 
relationship between  the  coexpression of these interacting 
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ture  investigations  must determine  whether the  expansion 
we  observed  is  mediated  through  signals  transmitted  by 
VHa2 stimulating CD5,  CD5 stimulating the Vrta2-associ- 
ated B  cell receptor (BCR) or both. Selective expansion of 
VHa2 + B cells in the appendix could occur via CD5-V, in- 
teraction  either  on  the  same  cell  or through  interactions 
with nearby cells in a developing cluster. 
A  role for CD5 as a candidate selecting ligand is further 
suggested  by  its  physical  and  functional  coupling  to  the 
BCtL  (25).  Thus  CD5  accessory molecules  in  the  BC1L 
complex on CD5 + B  cells  may have a unique potential to 
modulate BC1L signals after interaction with antigens or su- 
perantigens  (25,  26).  A  limited  repertoire  of V,  genes has 
been  observed in  the  CD5 + B  cell populations  of human 
and mouse  (27,  28).  This  may also reflect  selective B  cell 
expansion  during  fetal  and  neonatal  B  cell  development 
through interactions with autologous antigens or superanti- 
gens (10, 29). 
Studies  of the  phenotype  of a  CD5  knockout  mouse 
suggest  that  CD5  may play a  role  in positive  selection  of 
developing thymocytes with specific antigen receptors (30). 
Similarly,  the interaction between  CD5 as a surface ligand 
and its receptor on the same or other B  cells  may generate 
distinct activation signals at different stages of B  cell devel- 
opment and selection. As B lymphocytic leukemia cells ex- 
press CD5 (31), and CD5 + (BI) B  cells provide a source of 
autoantibody-producing  cells  (25-27),  the  CD5-frame- 
work  region  interaction  might  contribute  to  autostimula- 
tory growth of transformed  cells  as well  as  mediate  selec- 
tion of autoreactive repertoires.  CD5 may interact directly 
with a counterreceptor,  such as CD72  (32,  33)  or VH and 
transmit  modulating signals  to  the  B  cell.  The  amount  of 
signaling and qualitative differences in signaling may deter- 
mine  B  cell  negative  or positive  selection  (34).  CD5-VH 
interaction  alone  may induce  a  signal  that  is  sufficient  to 
promote expansion and/or survival of B  cells  or may influ- 
ence the fate of B  cell selection in combination with other 
signals. 
Our data provide evidence for CD5-V,  framework re- 
gion interaction and suggest it may affect maintenance and 
selective  expansion  of particular  B  cells.  After  V,  ligand 
recognition, CD5 stimulation may also be a promoting fac- 
tor in the evolution ofautoimmune or transformed cells. 
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